![]() ![]() ![]() A useful feature of CGM devices is the inclusion of alarms to notify patients when their glucose is outside of a pre-defined range. CGM automatically tracks glucose in interstitial fluid and is typically used in combination with occasional self-monitoring of blood glucose (SMBG). Traditional continuous glucose monitoring (CGM) is currently funded under the Swedish national health service, and adults with IAH are prioritised for reimbursement. The Tandvårds-Läkemedelförmånsverket (TLV), a national health authority in Sweden, recommends that adults with insulin-treated diabetes test at least four and up to ten times per day however, it also recognises that adherence is poor as finger-prick testing can be both time consuming, painful and inconvenient. Maintaining glucose levels within a recommended range reduces the risk of developing hypoglycaemia associated with an intensified insulin regimen. In addition to the high cost burden, hypoglycaemia is associated with worse quality of life, increased anxiety and reduced productivity. People with IAH are disproportionally high healthcare users due to a sixfold increase in the risk of severe hypoglycaemia. Prevalence estimates of IAH range between 20 and 32% in adults with insulin-treated type 1 diabetes mellitus (T1DM) and 10% in adults with insulin-treated type 2 diabetes mellitus (T2DM) and increases with age and duration of diabetes. IAH caused by recurrent, untreated and non-severe hypoglycaemic events results in patients being less aware and less able to respond to onset hypoglycaemia, putting them at higher risk of suffering severe hypoglycaemic events. Impaired awareness of hypoglycaemia (IAH) refers to the absence or diminished ability to perceive the onset of hypoglycaemia amongst diabetes patients. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |